Accurate tumor classification guides diagnosis, prognosis, and treatment decisions. This is particularly essential when morphologically similar tumors arise from different tissue lineages. STAT6 (signal transducer and activator of transcription 6) has emerged as a valuable diagnostic marker, as its expression pattern can help distinguish specific mesenchymal neoplasms from their histologic mimics. [Read more…]
Guide To The Stem Cell Donation Process
Stem cell donation can be an overwhelming topic for those considering it. However, the procedure itself is often simple to undergo. Here are the key aspects associated with the the stem cell donation process. [Read more…]
What is the Definition of Regenerative Medicine (RM)?
As with any rapidly evolving field, defining the scope and boundaries of regenerative medicine is a challenge. However, understanding this innovative industry requires examining the foundational components of the human body and the groundbreaking technologies designed to restore or enhance its function. To understand the definition of this scientific field, it is critical to understand the key components that compose the human body, which are: [Read more…]
BBG Advanced Therapies Launches Mobile Leukapheresis Center in Collaboration with Kite to Bring CAR T-cell Therapies Closer to Patients
BBG Advanced Therapies, a subsidiary of San Antonio-based nonprofit BioBridge Global, today announced a collaboration with Kite, a Gilead Company and global leader in cell therapy, to deploy BBG Advanced Therapies’ Mobile Leukapheresis Center (MLC) across Texas—marking an important milestone in how patients can access Kite’s CAR T-cell therapies which are individualized cancer treatments made from a patient’s own cells.
SAN ANTONIO, TX, July 7, 2026 – BBG Advanced Therapies, a subsidiary of nonprofit BioBridge Global (BBG), today announced a collaboration with Kite, a Gilead Company and global leader in cell therapy, to deploy BBG Advanced Therapies’ Mobile Leukapheresis Center (MLC) across Texas — marking an important milestone in how patients can access Kite’s CAR T-cell therapies which are individualized cancer treatments made from a patient’s own cells. [Read more…]
Osaka’s Cell Grand Clinic Named Top Regenerative Medicine Solution Provider in APAC 2026 — Standardizes Patient-Specific ADSC Therapy Across 13 Government-Certified Programs
Japanese government-certified clinic applies ISCT-compliant flow-cytometry release criteria to patient-specific adipose-derived stem cell cultures, serving patients from approximately 20 countries [Read more…]
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 63
- Next Page »